Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.580
+0.010 (0.64%)
At close: May 12, 2026, 4:00 PM EDT
1.590
+0.010 (0.63%)
After-hours: May 12, 2026, 6:00 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $114.23 million as of May 12, 2026. Its market cap has increased by 35.73% in one year.
Market Cap
114.23M
Enterprise Value
70.78M
1-Year Change
35.73%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $114.23M, a decrease of -76.64%. That is a compound annual growth rate of -24.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 114.23M | 30.30% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 122.00M |
| PepGen | 117.59M |
| Inovio Pharmaceuticals | 117.17M |
| Turn Therapeutics | 115.58M |
| Cardiff Oncology | 111.44M |
| Kalaris Therapeutics | 108.75M |
| Rani Therapeutics Holdings | 106.80M |
| Aldeyra Therapeutics | 106.17M |